Viking Therapeutics, Inc VKTX
$34.36
-4.50%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 4 | 4 | 2026-08-07 | View → |
| 4 | 4 | 2026-07-29 | View → |
| 4 | 4 | 2026-07-29 | View → |
| 4 | 4 | 2026-07-29 | View → |
| 10-Q | 10-Q | 2026-07-29 | View → |
| 8-K | 8-K | 2026-07-29 | View → |
| 4 | 4 | 2026-06-03 | View → |
| 8-K | 8-K | 2026-05-26 | View → |
| 10-Q | 10-Q | 2026-04-30 | View → |
| 8-K | 8-K | 2026-04-29 | View → |
| DEF 14A | DEF 14A | 2026-04-01 | View → |
| 4 | 4 | 2026-03-10 | View → |
| 10-K | 10-K | 2026-02-11 | View → |
| 8-K | 8-K | 2026-02-11 | View → |
| 4 | 4 | 2026-01-26 | View → |
| 4 | 4 | 2026-01-05 | View → |
| 4 | 4 | 2026-01-05 | View → |
| 4 | 4 | 2026-01-05 | View → |
| 4 | 4 | 2026-01-05 | View → |
| 4 | 4 | 2026-01-05 | View → |
| 4 | 4 | 2026-01-05 | View → |
| 4 | 4 | 2026-01-05 | View → |
| 4 | 4 | 2026-01-05 | View → |
| 4 | 4 | 2025-10-28 | View → |
| 4 | 4 | 2025-10-28 | View → |
| 4 | 4 | 2025-10-28 | View → |
| 4 | 4 | 2025-10-28 | View → |
| 10-Q | 10-Q | 2025-10-23 | View → |
| 8-K | 8-K | 2025-10-22 | View → |
| 8-K | 8-K | 2025-08-19 | View → |
| 10-Q | 10-Q | 2025-07-23 | View → |
| 8-K | 8-K | 2025-07-23 | View → |
| 4 | 4 | 2025-07-03 | View → |
| 4 | 4 | 2025-07-03 | View → |
| 4 | 4 | 2025-07-03 | View → |
| 8-K | 8-K | 2025-05-27 | View → |
| 10-Q | 10-Q | 2025-04-24 | View → |
| 8-K | 8-K | 2025-04-23 | View → |
| 8-K | 8-K | 2025-04-23 | View → |
| 4 | 4 | 2025-04-14 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $34.36
- Market Cap
- $4.20 billion
- 52-Week Range
- $22.96 – $43.15
- Average Volume
- 1.89 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.